170 related articles for article (PubMed ID: 18470514)
1. Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective.
Zanotti-Fregonara P; Rubello D; Hindié E
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1397-9. PubMed ID: 18470514
[No Abstract] [Full Text] [Related]
2. Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management.
Luster M
Acta Oncol; 2006; 45(8):1018-30. PubMed ID: 17118833
[No Abstract] [Full Text] [Related]
3. Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer.
Pacini F; Castagna MG
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):1009-21. PubMed ID: 19041828
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.
Skarulis MC
Rev Endocr Metab Disord; 2000 Apr; 1(3):147-54. PubMed ID: 11705000
[No Abstract] [Full Text] [Related]
5. Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter.
Woodmansee WW; Haugen BR
Clin Endocrinol (Oxf); 2004 Aug; 61(2):163-73. PubMed ID: 15272910
[TBL] [Abstract][Full Text] [Related]
6. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
[TBL] [Abstract][Full Text] [Related]
7. Clinical uses of recombinant human thyrotropin.
Gourgiotis L; Skarulis MC
Expert Opin Pharmacother; 2004 Dec; 5(12):2503-14. PubMed ID: 15571468
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human thyrotropin in the management of thyroid cancer.
McDougall IR; Weigel RJ
Curr Opin Oncol; 2001 Jan; 13(1):39-43. PubMed ID: 11148684
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human TSH: the Argentinean experience.
Pitoia F; Niepomniszcze H
Thyroid; 2009 Jul; 19(7):799. PubMed ID: 19508122
[No Abstract] [Full Text] [Related]
10. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
Perros P
J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003
[TBL] [Abstract][Full Text] [Related]
11. The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production.
Luster M; Reinhardt W; Korber C; Lassmann M; Haenscheid H; Michalowski U; Rendl J; Eising E; Mann K; Reiners C
J Endocrinol Invest; 2000; 23(7):473-5. PubMed ID: 11005273
[TBL] [Abstract][Full Text] [Related]
12. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH.
Sugino K; Ito K; Takami H
Endocr J; 2006 Dec; 53(6):723-8. PubMed ID: 16960401
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
[TBL] [Abstract][Full Text] [Related]
14. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky AZ; Freeman LM
J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
[No Abstract] [Full Text] [Related]
15. Thyrotropin in the development and management of differentiated thyroid cancer.
McLeod DS
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):367-83. PubMed ID: 24891167
[TBL] [Abstract][Full Text] [Related]
16. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions.
Mazzaferri EL; Kloos RT
Thyroid; 2000 Sep; 10(9):767-78. PubMed ID: 11041454
[TBL] [Abstract][Full Text] [Related]
17. The changing role of radioiodine in the management of differentiated thyroid cancer.
Reynolds JC; Robbins J
Semin Nucl Med; 1997 Apr; 27(2):152-64. PubMed ID: 9144857
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human thyrotropin is helpful in the follow-up and 131I therapy of patients with thyroid cancer: a report of the results and benefits using recombinant human thyrotropin in clinical routine.
Kohlfuerst S; Igerc I; Lind P
Thyroid; 2005 Apr; 15(4):371-6. PubMed ID: 15876162
[TBL] [Abstract][Full Text] [Related]
19. [Endocrinology and nuclear medicine aspects of the treatment of thyroid tumours].
Vicek P
Vnitr Lek; 2007; 53(7-8):807-11. PubMed ID: 17915423
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences].
Hasse-Lazar K; Handkiewicz-Junak D; Roskosz J; Szpak-Ulczok S; Krajewska J; Jurecka-Lubieniecka B; Jarzab B
Endokrynol Pol; 2006; 57(4):445-50. PubMed ID: 17006851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
